[1]
V. D. Prasasty and A. Yulandi, “STRUCTURE-BASED DESIGN OF NOVEL RILPIVIRINE ANALOGUES AS HIV-1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THROUGH QSPR AND MOLECULAR DOCKING”, Int J Pharm Pharm Sci, vol. 7, no. 11, pp. 340-345, Oct. 2015.